Position in HALO
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$570,040
+$87,061 QoQ
Shares Held
7,283
-2.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#374
of 664 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Net Worth Advisory Group holds $1,018,645 across 2 Biotechnology names. HALO ranks #1 (56.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
7,283 | $570,040 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
1,207 | $448,605 |
All Filings in HALO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $570,040 | 7,283 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $482,979 | 7,473 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $458,784 | 6,817 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $422,071 | 5,755 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $314,825 | 6,052 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $358,995 | 5,626 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $271,465 | 5,678 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $327,412 | 5,720 | Shares | Sole | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||